Notably, in heterotopic allografts of murine pancreatic cancer cells in immunocompetent syngeneic mice, treatment with the anti-BAG3 mAb sensitizes the tumors to the effect of an anti-PD-1 antibody [12]. The gene discussed is BAG3; the disease is familial pancreatic carcinoma.